GlassScriptPhysician profile
Neha Kapil
NPI 1740418227
$10,210.09
in general payments reported to CMS, 2019-2025
39 companies · $1,393 in 2025
The $1,393 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,486 · 2020: $1,253 · 2021: $1,326 · 2022: $1,596 · 2023: $1,730 · 2024: $1,425 · 2025: $1,393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,548.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,625.42 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Amgen INC. | $982.38 | 2019-2025 | Otezla, Repatha, Evenity |
| Glaxosmithkline, LLC. | $949.50 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $891.87 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $875.32 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $867.39 | 2021-2025 | |
| Lilly USA, LLC | $740.81 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Pfizer INC. | $635.69 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $385.95 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $331.98 | 2019-2025 | Gardasil 9, Capvaxive, Proquad |
| Gilead Sciences, INC. | $266.00 | 2019-2025 | |
| Astellas Pharma US INC | $195.61 | 2019-2025 | Veozah, Myrbetriq |
| Novartis Pharmaceuticals Corporation | $175.46 | 2022 | |
| Exact Sciences Corporation | $160.31 | 2023-2025 | Cologuard Collection Kit |
| Cranial Technologies, INC | $129.74 | 2019-2025 | Doc Band |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neha Kapil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.